Targeting the endothelial glycocalyx in acute critical illness as a challenge for clinical and laboratory medicine

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F17%3A10364165" target="_blank" >RIV/00216208:11140/17:10364165 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/17:10364165 RIV/00179906:_____/17:10364165 RIV/00669806:_____/17:10364165 RIV/44555601:13450/17:43894533

Výsledek na webu

<a href="http://dx.doi.org/10.1080/10408363.2017.1379943" target="_blank" >http://dx.doi.org/10.1080/10408363.2017.1379943</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1080/10408363.2017.1379943" target="_blank" >10.1080/10408363.2017.1379943</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Targeting the endothelial glycocalyx in acute critical illness as a challenge for clinical and laboratory medicine

Popis výsledku v původním jazyce

The purpose of this manuscript is to review the role of endothelial glycocalyx (EG) in the field of critical and perioperative medicine and to discuss possible future directions for investigations in this area. Under physiological conditions, EG has several well-defined functions aimed to prevent the disruption of vessel wall integrity. Under pathological conditions, the EG represent one of the earliest sites of injury during inflammation. EG structure and function distortion contribute to organ dysfunction related to sepsis, trauma, or global ischemia of any origin. Discovering new therapeutic approaches (either pharmacological or non-pharmacological) aimed to protect the EG against injury represents a promising direction in clinical medicine. Further, the currently-used common interventions in the acutely ill-fluids, blood products, nutritional support, organ-supporting techniques (e.g. continuous renal replacement therapy, extracorporeal circulation), temperature modulation and many others-should be re-evaluated during acute illness in terms of their EG &quot;friendliness&quot;. To assess new therapies that protect the EG, or to evaluate the effect of currently-used interventions on EG integrity, a relevant marker or method to determine EG damage is needed. Such marker or method should be available to clinicians within hours, preferably in the form of a point-of-care test at the bedside. Collaborative research between clinical disciplines and laboratory medicine is warranted, and targeting the EG represents major challenges for both. (C) 2017 Informa UK Limited, trading as Taylor &amp; Francis Group.

Název v anglickém jazyce

Targeting the endothelial glycocalyx in acute critical illness as a challenge for clinical and laboratory medicine

Popis výsledku anglicky

The purpose of this manuscript is to review the role of endothelial glycocalyx (EG) in the field of critical and perioperative medicine and to discuss possible future directions for investigations in this area. Under physiological conditions, EG has several well-defined functions aimed to prevent the disruption of vessel wall integrity. Under pathological conditions, the EG represent one of the earliest sites of injury during inflammation. EG structure and function distortion contribute to organ dysfunction related to sepsis, trauma, or global ischemia of any origin. Discovering new therapeutic approaches (either pharmacological or non-pharmacological) aimed to protect the EG against injury represents a promising direction in clinical medicine. Further, the currently-used common interventions in the acutely ill-fluids, blood products, nutritional support, organ-supporting techniques (e.g. continuous renal replacement therapy, extracorporeal circulation), temperature modulation and many others-should be re-evaluated during acute illness in terms of their EG &quot;friendliness&quot;. To assess new therapies that protect the EG, or to evaluate the effect of currently-used interventions on EG integrity, a relevant marker or method to determine EG damage is needed. Such marker or method should be available to clinicians within hours, preferably in the form of a point-of-care test at the bedside. Collaborative research between clinical disciplines and laboratory medicine is warranted, and targeting the EG represents major challenges for both. (C) 2017 Informa UK Limited, trading as Taylor &amp; Francis Group.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30223 - Anaesthesiology

Projekt

<a href="/cs/project/NV15-31881A" target="_blank" >NV15-31881A: Alterace glykokalyx v kritických stavech a během velkých operačních výkonů a možnosti její protekce</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Critical Reviews in Clinical Laboratory Sciences

ISSN

1040-8363

e-ISSN

—

Svazek periodika

54

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

15

Strana od-do

343-357

Kód UT WoS článku

000414146600004

EID výsledku v databázi Scopus

2-s2.0-85030843144